Drugs / CAR-TILs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04842812 | Jan 2021 → Dec 2029 expected | brain neoplasm, breast cancer, colorectal cancer, liver cancer +1 | Second Affiliated Hospital of Guangzhou Medical University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-TILs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04842812 ↗ |
| Modality | Cell therapy | “TILs and CAR-TILs injection” NCT04842812 ↗ |
| Route | Other | “transfuse them back the patients via systemic or local injections” NCT04842812 ↗ |